I think you both are on to something here. The ti

I think you both are on to something here. The timing of the vicriviroc data and Dr Jay’s letter/announcement prioritizing crc shouldn’t be ignored.

I remember laughing when people asked NP years ago about a dividend, years before revenue. Wonder if those folks are dreaming about MRK’s current dividend yield of 2.35%? Or maybe any other of the Big Pharmas who might end up acquiring?

The dreamers might have been way off on their timing but they might just end up being right in the end.